ibotenic acid has been researched along with methylphenidate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gressens, P; Husson, I; Kosofsky, B; Leroux, P; Medja, F; Mesplès, B | 1 |
| Dafny, N; Swann, AC; Wanchoo, SJ | 1 |
2 other study(ies) available for ibotenic acid and methylphenidate
| Article | Year |
|---|---|
Methylphenidate and MK-801, an N-methyl-d-aspartate receptor antagonist: shared biological properties.
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Brain Injuries; Dizocilpine Maleate; Dopamine Uptake Inhibitors; Ibotenic Acid; In Situ Nick-End Labeling; Methylphenidate; Mice; Neurons; Neuroprotective Agents; Piperazines; Receptors, N-Methyl-D-Aspartate | 2004 |
Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate.
Topics: Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Drug Administration Schedule; Glutamic Acid; Ibotenic Acid; Male; Methylphenidate; Motor Activity; Neural Pathways; Neurons; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Ventral Tegmental Area | 2009 |